Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorCentre Hospitalier National d'Ophtalmologie des Quinze-Vingts

About this trial

This study explores whether adding early nurse-led and psychological support after the diagnosis of retinitis pigmentosa (RP) can improve patient experience and emotional well-being. RP is a rare, progressive eye disease often diagnosed after a long and difficult process, and receiving the diagnosis can be emotionally distressing.

Eighty newly diagnosed adults will be randomly assigned to either usual care or an enhanced pathway that includes early follow-up with a nurse, structured emotional monitoring, and a psychologist visit at six months.

The study aims to determine if this structured support improves patient satisfaction and reduces anxiety and depression compared with standard care.

Eligibility criteria

Qualifiers

Diagnosed with retinitis pigmentosa (RP) and followed at the Quinze-Vingts Rare Eye Disease Center, with diagnosis made after the project begins

Aged 18 to 65 years

Male or female

French-speaking

Disqualifiers

Pregnant women

Participants enrolled in a therapeutic clinical trial within the past 12 months

Individuals deprived of liberty by judicial or administrative decision

Adults under legal protection or unable to provide informed consent

Trial design

Treatments tested in this trial

  • Enhanced post-diagnostic support
  • Usual Care

Treatment groups

80 Participants
are divided into 2 treatment groups